Innovate (VATE) shares soared nearly 61% amid heavy trading after the company said late Friday that the US Food and Drug Administration approved its MediBeacon platform to assess kidney function.
Over 17.4 million shares traded intraday versus a daily average of roughly 43,000.
Redwire (RDW) said Monday that it agreed to acquire Edge Autonomy in a cash and stock deal worth $925 million, expanding its space platforms portfolio.
Shares of Redwire advanced 43% as intraday trading volume soared to more than 7.9 million from a daily average of about 888,000.
Moderna (MRNA) disclosed late Friday a $590 million award by the US Department of Health and Human Services to accelerate the development of mRNA-based pandemic influenza vaccines.
Shares jumped 6.5%, with intraday trading volume rising to over 9.4 million compared with a daily average of about 9.1 million.
Price: 8.22, Change: +3.11, Percent Change: +60.86
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.